ES
MARKETS / NYSE / RVTY
NYSE · LABORATORY ANALYTICAL INSTRUMENTS · LARGE CAP

Revvity, Inc. RVTY

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.9B
▲ 3.7% vs FY2024
EPS · FY25
$2.07
Dividend / sh · FY25
$0.28
Payout · FY25
14%
ROE · FY25
3.2%
Net margin · FY25
8.4%
Dividend coverage
7.4×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.9B
Revenue, FY2025 · full 18-year series below
Revenue Net income
12342.90.22008201120142017202020232025
12342.90.22016201920222025

8 cents of every revenue dollar became profit this year.

Per share
USD 2.07
Diluted EPS, FY2025
EPS Dividend
48120.282.072008201120142017202020232025
48120.282.072016201920222025

Earnings covered the dividend 7.4 times — the rest stayed in the company.

Profitability
3.2%
Return on equity, FY2025
ROE
816243.2%2008201120142017202020232025
816243.2%2016201920222025
Operating margin12.5%
Net margin8.4%
Return on assets2.0%

Each USD of equity produced 3 cents of profit this year.

Returned to shareholders
USD 853.6M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 32.8M
Net buybacksUSD 820.8M
Share of profit353.9%
Consecutive raises—

USD 32.8M in dividends and USD 820.8M in buybacks — 354% of the year's profit, so the payout drew on cash built up earlier.

Growth
+1.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−4.8%
+1.4%
+3.1%
+3.5%
Net income
−24.9%
−19.8%
+1.3%
−3.2%
EPS, diluted
−22.8%
−20.4%
+1.0%
−3.1%
Dividend / share
+0.0%
+0.0%
+0.0%
+0.0%
Returned to shareholders
+94.5%
+86.2%
+23.0%
+14.9%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.11B
Shares outstanding, FY2025
0.120.112008201120142017202020232025
0.110.112016201920222025
Change, 5 years+0.2%
Change, 10 years−0.2%

The share count grew 0% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 12.2B
total assets, end of FY2025
Total assetsUSD 12.2B
EquityUSD 7.3B
CashUSD 919.9M
Gross debtUSD 3.2B
Net debtUSD 2.3B
Current ratio1.68×

Net debt stands at 32% of equity.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
2.9
2.8
2.8
3.3
3.8
2.7
2.9
2.8
2.3
2.1
2.1
2.1
2.2
2.1
1.9
1.7
1.6
1.7
Operating income $B
0.4
0.3
0.3
0.7
1.3
0.9
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.1
0.1
0.2
0.1
0.1
EBITDA $B
0.8
0.8
0.7
1.2
1.6
1.1
0.6
0.5
0.4
0.4
0.4
0.3
0.4
0.2
0.2
0.2
0.2
0.2
Income tax $B
0.0
0.0
0.0
0.1
0.3
0.2
0.0
0.0
0.1
0.0
0.0
−0.0
−0.0
−0.0
0.1
0.0
0.0
0.0
Net income $B
0.2
0.3
0.7
0.6
0.9
0.7
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.1
0.0
0.4
0.1
0.1
EPS, diluted $
2.07
2.20
5.55
4.50
8.08
6.49
2.04
2.13
2.64
2.12
1.87
1.39
1.47
0.61
0.07
3.31
0.70
1.07
Dividend / sh $
0.28
0.28
0.28
0.28
·
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
0.28
·
·
Payout %
14
13
5
6
3
4
14
13
11
13
15
20
19
46
416
8
40
26
ROE %
3.2
3.5
9.1
7.8
17.3
22.2
8.4
9.4
12.6
11.0
10.2
7.8
8.5
3.7
0.4
22.0
5.1
8.1
Shares out B
0.11
0.12
0.12
0.13
0.13
0.11
0.11
0.11
0.11
0.11
0.11
0.11
0.11
0.12
0.11
0.12
0.12
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
52 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 8 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed